Tacrine (THA) and physostigmine (PHS) have been used in Alzheimer's disease therapy for their anticholinesterasic activity. Here we show that THA is taken up in rat lysosomes in an energy-dependent manner, and that it is also accumulated in acidic compartments of rat thymocytes and neuroblastoma cells. A concentration of THA less than 1 mM dissipated the pH gradient (ApH) in all the above mentioned in vitro systems. On the contrary higher concentrations of PHS (1-2 mM) were ineffective. The accumulation of THA in acidic organelles of the cell may be relevant for the pharmacological action of THA in Alzheimer's treatment.
Introduction
Alzheimer's disease (AD) is associated with severe impairment on the activity of different physiological and biochemical processes in the brain. Among different pharmacological strategies used in AD treatment suggested by the biochemical changes found in the cholinergic system, the most promising results were obtained using anticholinesterasic compounds, such as physostigmine (PHS) and tacrine (THA) [1] .
THA has been shown to possess the most promising therapeutic efficacy, in spite of its lower in vivo [2] and in vitro [3] inhibitory effect of cholinesterase activity compared to PHS. This observation suggested that the cholinesterase inhibition in the synaptic cleft may not be the only effect of THA. A multiple action mechanism has been recently suggested for THA, including effects on the cholinergic system, interaction with cholinergic receptors, effects on the monoaminergic system, inhibition on the release and uptake of catecholamines and serotonin [3] .
In the present study we focused our interest on the localization of THA and PHS in the cell. It is well known that the a typical eukariotic cell contains many acidic organelles belonging both to the endocytic and the secretory pathway [4] . THA is a weak base (pK a = 10); provided that its unprotonated neutral form is membrane permeant, the drug is expected to accumulate inside acid organelles by protonation, as acridine orange (AO) [5] [6] [7] and other amines do, following the classic mechanism proposed for the uptake of weak bases in the lysosomes [8, 9] .
In order to investigate such a hypothesis, we tested the effect of THA and PHS on the accumulation of the dye acridine orange in rat liver lysosomes and acidic compartments of rat thymocytes or neuroblastoma cells.
In addition, the drug accumulation in some of the above systems was also measured. We found that THA, but not PHS accumulated both in lysosomes and in acidic compartments of the cell. The relevance of this finding with respect to a possible action mechanism of THA will be discussed.
Materials and methods
Tacrine (9-amino,l,2,3,4-tetrahydroacridine) and physostigmine (Scheme 1) were purchased by Aldrich. Nigericin was obtained from Sigma. Rat liver lysosomes were prepared by centrifugation in a self generating Percoll (Sigma) gradient [6] , from a lysosome enriched preparation, and resuspended in Hepes buffer 20 mM pH 7.4 containing KC1 (or, as specified, choline-Cl 125 mM), and MgC12 4 mM.
Rat thymocytes were isolated as previously described [10] from male Wistar rats weighing 150-200 g. Cells were mantained at room temperature in a simplified saline solution containing NaC1 135 mM, KCI 5 mM, NaHCO 3 5 mM, glucose 5.5 mM, MgC12 4 mM, Hepes buffer 20 mM pH 7.4 or, in some cases, in the some medium without glucose and containing oligomycin 1.5/zg/ml. Cell viability was > 95%, also after two or more hours of incubation in either medium. Protein assay was carried out using the classic biuret method [11] and bovine serum albumin as a standard.
Murine neuroblastoma C 1300 (clone Neuro 2A) cells (N2A) were obtained from the American Type Culture Collection. Cells were grown in Dulbecco's modified medium (DMEM) and resuspended, before use, in the glucose medium described above.
Acridine Orange (AO) (Aldrich) uptake by lysosomes (ATP-driven) and by rat thymocytes was monitored spectrophotometrically as previously described [5, 7] . To determine the amount of AO taken up by lysosomes, a suspension of these organelles was centrifuged at 30 000 × g for 15 min (Sorvall RC 2B, 5534), 20 min after from the addition of 2 mM ATP. AO in the supernatant was estimated by measuring the absorbance at 492 nm using a calibration curve. Since THA and PHS do not absorb in the visible spectral region nor affect the AO absorbance (at 492 nm), this allowed the use of AO, as zapH probe, in the presence of the drugs. To measure THA or PHS uptake by thymocytes, cells treated with the drug for 30 min, were centrifuged at low speed; the supematant was then supplemented with 3% HC104 to eliminate residual protein content and centrifuged as described for lysosomes. THA or PHS concentrations in the supernatant were measured at 335 and 320 nm respectively, using a calibration curve. A similar procedure was followed to measure THA uptake by lysosomes except that lysosomes were removed by centrifugation at 30 000 × g, following a 20 min incubation with the drug. Cells or lysosomes incubation with the drugs were performed at 37 ° C, AO uptake at room temperature. Unless otherwise indicated, experiments were carried out at least three times using each time a new preparation of lysosomes or cells. Fig. 1 reports the acidification of rat liver lysosomes produced by the H+-ATPase pump as monitored photometrically by using the ApH probe AO. Addition of NH~ which is know to dissipate the ApH (trace a) or of THA (trace b) elicited the release of the AO dye, reflecting a collapse of the ApH. A similar effect was observed with nigericin 1 /xg/ml (not shown, see [5] ). PHS on the contrary, did not show such an effect (trace c). 50% and 100% dye release was caused by about 0.15 mM and 0.8-1 mM THA, respectively (Fig. ld) . Fig. 2 shows the acidification of lysosomes (using a K+-free medium) mediated by nigericin, which causes a H ÷ uptake in exchange with intralysosomal K ÷. Addition of THA, similarly to NH~, reversed the change in dye absorbance, indicating that the effect of THA on dpH shown in Fig. 1 was not due to the inhibition of lysosomal H+-ATPase, but rather to the accumulation of THA as a weak base into lysosomes.
Results

Dissipation of ApH by THA
The uptake of AO in the lysosomes, caused by the H+-ATPase and the consequent release of the dye by THA, were measured in the supernatant upon centrifuga- Lysosomes, incubated for 20 min with 10 /.LM AO in the absence or presence of ATP were then treated with 700 ~M THA or 20 mM NH2 or did not receive any addition. Few min later (4-5), the lysosomes suspension was centrifuged as described in Materials and methods. In the absence of ATP, NH~ or THA had no effect on the dye uptake (not shown). Data + S.D. refer to at least three experiments using each time a different preparation.
tion of the lysosomal suspension. ATP strongly increased the dye uptake by lysosomes and the following addition of THA or NH ~, reversed the above-mentioned increase (Table 1). Fig. 3 shows a spectrophotometric analysis of the uptake of AO by rat thymocytes and of its accumulation into acidic compartments. This phenomenon is probably a result of both passive and active transport. Even in this system THA or NH~ traces a, b) or nigericin (not shown, see [7] ) reversed the dye uptake, while PHS was totally ineffective. 50% and 100% dye release was caused by about 0.3 mM and 0.8-1 mM THA respectively (Fig. 3c) . In cells incubated for 2 h in a glucose-free medium supplemented with the mitochondrial ATP-synthetase inhibitor oligomycin the dye uptake was strongly (70-80%) inhibited (trace d). This finding further strengthens the view that the dye accumulation involves intracellular acidic compartments. AO uptake was also (spectrophotometrically) assessed in N2A cells; a consistent dye uptake by these cells was found, that was completely reversed by THA, at the concentrations described above, indicating that the drug was able to dissipate intracellular pH gradients also in these cells (Fig. 3 , trace e).
THA uptake by lysosomes or thymocytes
Further evidence of THA accumulation inside the lysosomes or in the acidic compartments of thymocytes was obtained by a direct measurement of THA uptake (Table  2) . Differently from AO, THA was taken up by lysosomes at a low level in the absence of ATP, but a consistent increase in THA uptake was observed when ATP was present. As expected, NH~ or nigericin released the drug accumulated in the lysosomes through the ATP-driven proton pump. A comparative study of THA or PHS uptake by thymocytes is also presented in Table 2 . The uptake of the THA was partially reversed by NH~ Conversely nigericin greatly increased the extent of THA uptake, despite the fact that, under the same conditions, the ionophore does collapse the ApH, as above mentioned. Effects of NH~, nigericin or metabolic inhibitors. NH~ (20 mM) or nigericin (1.5 /~g/ml) were added (when indicated) after incubation of lysosomes (20 rain) or thymocytes (30 min) with THA or PHS 80 /xM (as indicated). 4-5 min later, the suspension was centrifuged and further processed as described in Materials and methods. The last line shows THA uptake by cells incubated at room temperature for 2 h in a glucose-free medium supplemented with oligomycin 1.5 ~g/ml. No change in average THA uptake by thymocytes (in the standard medium) was detected even 2 h after cell preparation. Therefore, data obtained at 2 h were included in the average (line 1). Unless otherwise indicated (number between brackets), data + S.D. refer to at least three experiments using different lysosomes or cell preparations.
This effect of nigericin can be easily explained by considering that nigericin, at low external potassium concentration, causes a cytoplasmic acidification [12] which in turn drives THA uptake into the cytoplasmic compartment. Addition of NH + caused a partial reversion of the THA uptake induced by nigericin.
In Table 2 is also shown that when cells were incubated for 2 h in a glucose-free medium containing the mitochondrial ATP-synthetase inhibitor oligomycin, a consistent lowering (on an average, about 60% of the total, 75% of the NH~--sensitive fraction) of THA uptake by cells (in respect to cells incubated in the standard medium) was observed, similar in extent to that of AO (see Fig. 3d ).
PHS uptake by thymocytes was much lower than that of THA and unaffected by NH~.
Discussion
Our findings indicate that the anticholinesterasic drug THA enters isolated rat liver lysosomes and rat thymocytes or N2A cells whereby it accumulates inside acidic vesicles.. In intact cells this was indirectly supported by the finding that in metabolically inhibited cells we found a strong inhibition of THA uptake similar in extent to that seen with AO (that, as it is well known, accumulates in acidic vesicles [7] . The finding that a similar result was observed using different cell types strongly supports that the mechanism involved in drug accumulation is unspecific and likely that proposed for weak bases uptake by the cell lysosomes [9] . Conversely, a different anticholinesterasic drug, PHS, is unable to accumulate in acidic compartments under the same conditions. This was largely unexpected considering the pK a values of the two dissociable protons of this drug (pK 1 7.9, pK 2 = 1.89 [13] ). However, considering the high lipophilicity of this drug (data not shown), the failure of the drug to accumulate could be due to a high membrane permeability of the charged form too, that should prevent trapping by protonation. The different behaviour of the two drugs rises the question whether our results can be relevant with respect to the different therapeutic efficacy reported for the two drugs [3] . Any modification on the lumenal pH of acidic compartments of the cell induced by the drug itself should play a minor role, considering that the drug concentration required to significantly affect pH is much higher than that used in clinical trials (< 1 /~M) [3] . However, the observation that acidic compartments are the primary targets of THA, but not PHS, may carry other relevant implications for the action mechanism of the drugs. It is well known that most vesicles belonging to the secretory pathway, including cholinergic synaptic vesicles of neuronal cells, have a low lumenal pH [14] [15] [16] [17] [18] . This is also most likely true for the 'large dense core' neuronal secretory vesicles, which differ from the above and are considered very similar to the secretory vesicles of the endocrine cells [19] . These organelles contain a variety of substances including neurotransmitter processing enzymes [20, 21] . Moreover, acetylcholinesterase is secreted from neuronal structures such as subcisternal dendritic vesicles [22, 23] . Thus, it can be speculated that THA is released into the synaptic cleft together or concomitantly with neurotransmitters and this might provide a high drug concentration in the synaptic cleft where the action of the drug is required. Another possibility is that the drug could interact in a more favorable condition, due to its higher concentration, with acetylcholinesterase or other enzymes involved in the cholinergic transmission, inside secretory vesicles. In addition one could speculate that the accumulation inside intracellular vesicles results in a longer availability of the drug, prolonging therefore its pharmacological effects, by release of drug while its concentration becomes progressively lower in the extracellular space. This observation is consistent with the different half-life reported for THA (3-4 h) and for PHS (30 min) [24] .
